3,560 material Form 8-K filings that 2,489 companies we cover made with the SEC in October 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). 2,508 of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Kimberly-Clark extended the expiration date of its offers to exchange up to $7.0 billion of Kenvue notes for new Kimberly-Clark notes, from October 27 to November 2, 2026. The exchange offers are conditioned on completing its pending acquisition of Kenvue, which the company cannot waive, so the extension keeps the financing step tied to that deal on schedule.
Expiration date moved from 5:00 p.m. New York time on October 27, 2026 to 5:00 p.m. on November 2, 2026, and may be extended further.
Tendered amounts as of October 27, 2026 ranged from 73.93% to 98.54% of outstanding principal across seven note series.
Amendments to the Kenvue indenture were approved on October 9, 2026 and take effect only when the exchange offers settle.
The offers are conditioned on completion of the Kenvue acquisition, a condition Kimberly-Clark may not waive.
Enerpac Tool Group signed a First Amendment on October 27, 2026 to its July 7, 2026 merger agreement to acquire Specialized Fabrication Equipment Group LLC. The amendment moves restricted stock unit awards for SFE Group key personnel, issued in place of cash transaction bonuses, to a newly adopted Inducement Award Plan, and adds related closing conditions and clarifications on the merger consideration adjustment. The filing gives no deal value or financial impact figures, so the change is administrative in nature for shareholders.
Amendment dated October 27, 2026 to the Agreement and Plan of Merger dated July 7, 2026
Key SFE Group personnel RSU awards, in place of cash transaction bonuses, move from the 2017 Omnibus Incentive Plan to the new Inducement Award Plan
Adds a covenant and closing conditions requiring key personnel to sign award agreements under the Inducement Plan
A. O. Smith agreed to sell an 81% equity interest in its China business to CPE, an alternative asset manager, subject to closing conditions and regulatory approvals. The company keeps a 19% stake and a long-term brand license, and expects the deal to close in the first half of 2027. The company says it intends to use after-tax proceeds and repatriated cash mainly for share repurchases.
China business valued at about $400 million on a cash-free, debt-free basis; total value including licensing economics expected to exceed $500 million
About $80 million of cash currently held in China would be repatriated
A. O. Smith retains a 19% interest and receives royalties under a long-term brand license
Expected close in the first half of 2027; third quarter results and guidance due October 29, 2026
Sands China Ltd., Las Vegas Sands' majority-owned subsidiary, priced $700 million of 6.400% senior notes due 2032 and $300 million of 6.700% senior notes due 2033, with closing expected November 3, 2026. The company plans to use net proceeds of about $989 million, together with cash on hand, to redeem its $700 million 2.300% notes due 2027 and repay its 2024 SCL Revolving Facility balance, which refinances existing debt and adds new long-term borrowing at the subsidiary level.
Priced $700 million of 6.400% senior notes due 2032 and $300 million of 6.700% senior notes due 2033
Offering expected to close on November 3, 2026, subject to customary closing conditions
Net proceeds of approximately $989 million plus cash on hand to redeem $700 million 2.300% notes due 2027 and repay the 2024 SCL Revolving Facility balance
Notes are unregistered and offered only to professional and qualified institutional investors; Sands China proposes a Hong Kong Stock Exchange listing
Bread Financial Holdings priced an underwritten public offering of 5,000,000 depositary shares, each representing a 1/40th interest in its 9.375% Series C fixed rate reset non-cumulative perpetual preferred stock. The company expects approximately $120,162,500 in net proceeds, assuming no exercise of the underwriters' option, for general corporate purposes that may include contributing or lending funds to its subsidiary bank, Comenity Capital Bank, and share repurchases. Shareholders will see new preferred securities outstanding once the offering closes, expected November 3, 2026.
5,000,000 depositary shares priced, each with a $25 liquidation preference (equivalent to $1,000 per Series C preferred share)
Underwriters have a 30-day option to buy up to an additional 750,000 depositary shares at the same price
Expected net proceeds of approximately $120,162,500 without option exercise; closing expected November 3, 2026
Proceeds may fund general corporate purposes, including contributions or loans to Comenity Capital Bank and share repurchases
OppFi reported third-quarter 2026 results for the period ended September 30, 2026, with total revenue and profit both lower than a year earlier. The company also refined its full-year 2026 guidance, now calling for total revenue of $600 million to $610 million and adjusted EPS of $1.34 to $1.40, and said it launched a new line of credit product during the quarter.
Q3 total revenue was $149.2 million, down 3.8% from $155.1 million a year earlier.
Q3 net income attributable to OppFi Inc. was $34.5 million, down 17.2% from $41.6 million; diluted EPS was $0.40 versus $0.77.
Q3 adjusted EPS was $0.37, down 20.1% from $0.46; full-year 2026 adjusted EPS guidance is $1.34 to $1.40.
TXNM Energy disclosed that hearing examiners at the New Mexico Public Regulation Commission published a revised procedural schedule for the merger application on October 27, 2026. Evidentiary hearings are set for January 19 to February 1, 2027. TXNM still expects the merger with Troy ParentCo to close in the first half of 2027, but says it cannot predict the outcome.
NMPRC hearing examiners set evidentiary hearings for January 19 to February 1, 2027
The merger still requires NMPRC approval and satisfaction or waiver of customary conditions
TXNM continues to anticipate the merger closing in the first half of 2027
Monarch Casino & Resort reported third-quarter 2026 net revenue of $146.3 million, up 2.4%, with net income of $32.0 million, up 1.4%, and diluted EPS of $1.76, up 4.1% from a year earlier. The company also declared a $0.30 per share cash dividend payable December 15, 2026, and reported $137.4 million in cash with no credit facility borrowings.
Q3 2026 net revenue $146.3 million vs. $142.8 million a year earlier; net income $32.0 million vs. $31.6 million
Diluted EPS $1.76 vs. $1.69; Adjusted EBITDA $56.0 million, up 2.1%
Quarterly cash dividend of $0.30 per share, payable December 15, 2026 to holders of record December 1, 2026
Q3 SG&A rose to 19.8% of net revenue from 19.3%, mainly due to higher legal and employee-related expenses
OGE Energy reported third quarter 2026 diluted earnings of $1.52 per share, up from $1.14 a year earlier, on net income of $316.2 million versus $231.3 million. The company now expects 2026 consolidated earnings of $2.62 to $2.68 per diluted share, above its original guidance range, citing warmer than normal weather.
Q3 2026 diluted EPS was $1.52 versus $1.14 in Q3 2025; net income was $316.2 million versus $231.3 million.
Operating revenues rose to $1,182.8 million from $1,045.0 million, with OG&E's results driven by significantly warmer weather.
2026 guidance now calls for consolidated earnings of $2.62 to $2.68 per diluted share, assuming normal weather for the rest of the year.
Seven Hills Realty Trust reported third quarter 2026 net income of $8.1 million, or $0.36 per diluted share, up from $3.4 million, or $0.23 per share, in the same quarter of 2025. Distributable Earnings were $3.8 million, or $0.17 per share, after a $1.5 million realized loss on a Dallas office loan; excluding that loss, they were $5.3 million, or $0.24 per share, compared with $0.29 a year earlier. The company also originated $122.3 million of loans in the quarter, its highest quarterly level since the fourth quarter of 2021.
Q3 2026 net income was $8.1 million, or $0.36 per diluted share, versus $3.4 million, or $0.23 per share, in Q3 2025.
Distributable Earnings were $3.8 million, or $0.17 per share; excluding a $1.5 million realized loss, they were $5.3 million, or $0.24 per share.
Three loans with aggregate commitments of $122.3 million were originated in the quarter, and the company had $51.5 million of cash and $425.7 million of unused financing capacity at September 30, 2026.
The board declared a quarterly distribution of $0.28 per common share on October 8, 2026, payable on or about November 12, 2026, to holders of record on October 19, 2026.
Red Robin directors James C. Pappas and Christopher Martin resigned from the board and all committees, effective October 23, 2026, and the company said the resignations were not related to any disagreement over operations, policies or practices. The company plans to cut the board from eight to six directors, five of whom will be independent, and says the departures follow its refranchising program and a new $115 million credit facility.
Pappas (JCP Investment Management) and Martin (Jumana Capital) resigned effective October 23, 2026.
Board size will decrease from eight to six directors, five of whom will be independent.
New five-year, $115 million senior secured credit facility, led by JPMorgan Chase Bank, N.A., includes a $90 million term loan and a $25 million revolving credit facility.
Pappas and Martin joined the board in December 2024 in connection with an additional investment by Jumana and JCP.
First Commonwealth Financial reported third-quarter 2026 net income of $44.9 million, or $0.45 per diluted share, up from $44.6 million, or $0.44, in the second quarter and $41.3 million, or $0.39, a year earlier. The company also declared a $0.14 quarterly dividend and authorized an additional $25 million share repurchase program, but provision expense rose to $14.2 million and nonperforming loans increased to $95.2 million.
Net interest margin was 4.11%, up 10 basis points from the prior quarter and 19 basis points from a year earlier.
Provision for credit losses was $14.2 million, up from $8.9 million in the second quarter, and nonperforming loans rose $13.6 million to $95.2 million.
Quarterly dividend of $0.14 per share is payable November 20, 2026, to holders of record as of November 6, 2026.
Board authorized an additional $25 million share repurchase program on October 27, 2026.
Rush Enterprises reported third-quarter 2026 revenue of $2.113 billion, up 12.4% from a year earlier, and net income attributable to the company of $78.0 million, or $0.65 per diluted share, versus $66.7 million, or $0.55, in the prior-year quarter. The board also declared a quarterly cash dividend of $0.14 per share, payable December 10, 2026, to shareholders of record as of November 11, 2026.
Q3 2026 revenue $2.113 billion, up 12.4% from $1.881 billion in Q3 2025
Net income $78.0 million, or $0.65 per diluted share, vs. $66.7 million, or $0.55, a year earlier
New U.S. Class 8 truck sales of 3,880 units, up 24.4% from Q3 2025, per the filing
Quarterly dividend of $0.14 per share, payable December 10, 2026; record date November 11, 2026
On October 27, 2026, Aclaris Therapeutics entered an underwriting agreement to sell 7,785,714 shares of common stock at $3.50 each, plus pre-funded warrants for 6,500,000 shares, in an offering under an effective Form S-3 registration. The Company estimates net proceeds of about $46.7 million, with closing expected on October 28, 2026. Because the offering adds new shares and warrants, existing shareholders' ownership percentage could be diluted.
7,785,714 common shares offered at $3.50 per share
Pre-funded warrants for 6,500,000 shares priced at $3.49999 each, with a $0.00001 exercise price
Estimated net proceeds of about $46.7 million; closing expected October 28, 2026
Underwriters include Leerink Partners LLC, Piper Sandler & Co. and Cantor Fitzgerald & Co.
Hydrofarm sold about 8.6 million common shares and pre-funded warrants at $0.905 per share in a registered direct and private placement, with gross proceeds of $8.3 million before fees and expenses. Investors also received common warrants for up to 9,210,975 shares at $0.78, which dilutes existing holders and adds potential future share issuance. The filing also describes side letter and registration terms with lenders tied to a restructuring, including rights to designate board members subject to stockholder approval.
Registered direct offering of 1,599,400 shares at $0.905 per share, plus a concurrent private placement of 6,971,575 shares and pre-funded warrants for 640,000 shares, all closed October 27, 2026.
Common warrants for up to 9,210,975 shares at $0.78 per share expire 5.5 years after issue; the placement agent, ThinkEquity LLC, receives a cash fee of 8% of the purchase price.
Under a side letter with lenders, the lenders may designate 1 initial director and up to 3 additional directors, subject to stockholder approval under Nasdaq Rule 5635.
The company must file a resale registration statement by the 15th calendar day after the registration rights agreement date, or pay partial liquidated damages of 2.0% of the subscription amount for each affected holder.
CBIZ stockholders approved the Agreement and Plan of Merger with Viking ParentCo, Inc. at a virtual special meeting on October 27, 2026. Holders of 40,439,369 shares, or 73.6% of shares outstanding as of the September 16, 2026 record date, attended or were represented by proxy. The company expects the merger to close on or about November 2, 2026, after which it will be a wholly owned subsidiary of Parent.
Merger Agreement Proposal: 39,198,360 for, 1,180,759 against, 60,250 abstentions.
Merger-related compensation advisory vote, which is non-binding: 37,188,161 for, 3,130,664 against, 120,544 abstentions.
Adjournment proposal was not presented because there were sufficient votes to approve the merger agreement.
Expected closing date: on or about November 2, 2026.
Spero Therapeutics announced that Chief Operating Officer Timothy Keutzer will retire effective December 31, 2026, after 11 years with the company. He is expected to serve as a consultant through approximately February 28, 2027 to support the leadership transition.
Timothy Keutzer, Chief Operating Officer, retires effective December 31, 2026
Consulting arrangement expected to run until approximately February 28, 2027, terminable by either party on fifteen days' written notice
Keutzer will be paid an hourly rate during the consulting period; the filing gives no dollar figure
Healthcare Triangle, Inc. completed a 1-for-20 reverse stock split effective October 26, 2026, reducing its common shares outstanding from 17,730,008 to 886,587. The company said the split is intended to meet Nasdaq's $1.00 minimum bid price requirement. Nasdaq has issued a Staff Delisting Determination, and a Nasdaq Hearings Panel hearing is scheduled for November 5, 2026, with no assurance the company will keep its listing.
1-for-20 reverse split effective 12:01 a.m. ET on October 26, 2026; shares trade split-adjusted on the Nasdaq Capital Market under HCTI
Common shares outstanding reduced from 17,730,008 to 886,587; authorized shares unchanged
Nasdaq Staff Delisting Determination received October 1, 2026; company requested a Panel hearing October 8, 2026
Hearing before the Nasdaq Hearings Panel scheduled for November 5, 2026; company states there can be no assurance of continued listing
Sound Financial Bancorp reported third-quarter 2026 net income of $2.3 million, or $0.90 per diluted share, down from $2.5 million, or $0.98, in the prior quarter and up from $1.7 million, or $0.66, a year earlier. The board also declared a regular quarterly cash dividend of $0.21 per share, payable November 20, 2026 to holders of record on November 6, 2026.
Q3 2026 net income $2.3 million, $0.90 diluted EPS, versus $0.98 in Q2 2026 and $0.66 in Q3 2025
Net interest margin rose to 3.76% from 3.74% in Q2 2026 and 3.48% in Q3 2025
Total loans held-for-portfolio fell to $878.0 million from $892.0 million in Q2 2026; nonperforming loans rose to $8.5 million from $2.7 million a year earlier
Quarterly cash dividend of $0.21 per share, payable November 20, 2026
Enerpac Tool Group amended the offer letter of President and CEO Paul Sternlieb, setting out how his equity and cash incentives would be treated if he retires after a specified date, with a retirement date no earlier than July 31, 2030. The amendment also raises his change-in-control and severance benefits, which the company says is meant to keep him in the role and support a leadership transition.
Amendment dated October 26, 2026 sets a retirement notice period of 180 days, with windows starting in February 2030.
Severance multiples rise to 2 times base salary and annual incentive from 1.5 times; welfare premium coverage rises to 24 months from 18 months.
Legal fee reimbursement limits rise to $50,000 from $10,000 for enforcing severance terms, plus up to $50,000 for negotiating the amendment.
The amendment does not change Mr. Sternlieb's base salary, target bonus, or annual long-term equity award opportunity.
Renasant agreed to merge with Commercial Holding Company, parent of Commercial Bank & Trust, with Commercial shareholders receiving 0.8798 Renasant shares for each Commercial share, about 2.64 million shares in total. Including a $35.7 million pre-closing special cash dividend, the filing puts the aggregate transaction value at about $142 million, based on a $40.29 10-day average RNST price. The deal is expected to close in the first quarter of 2027, subject to regulatory approvals and Commercial shareholder approval, and would add Commercial Bank's roughly $1.1 billion in assets to Renasant's West Tennessee presence.
Commercial shareholders to receive 0.8798 Renasant shares per share, about 2.64 million shares in aggregate
Aggregate transaction value about $142 million, including a $35.7 million special cash dividend
Commercial to pay a $7,000,000 termination fee under certain circumstances
Expected closing in the first quarter of 2027, subject to regulatory and Commercial shareholder approvals
Blackstone's indirect subsidiary, Blackstone Reg Finance Co. L.L.C., priced an underwritten public offering of $1.1 billion in senior notes, with the notes fully guaranteed by Blackstone and five related Blackstone Holdings partnerships. Blackstone said it intends to use the net proceeds for general corporate purposes, and the filing does not describe any change in operating results or guidance.
$600 million of 5.650% senior notes due 2031 priced
$500 million of 5.900% senior notes due 2033 priced
Notes offered under a shelf registration statement filed December 2, 2024, as amended February 27, 2026
Net proceeds to be used for general corporate purposes
Modine Manufacturing adopted an Executive Severance Plan on October 21, 2026, covering CFO Michael Lucareli and General Counsel Erin Roth, and approved enhanced severance and equity award changes for CEO Neil Brinker and other executives around October 21 to 27, 2026. The changes expand payouts tied to a change in control and broaden the definition of good reason, which the company says aligns its arrangements with current market standards.
Executive Severance Plan adopted October 21, 2026; Lucareli set at 1.5x regular and 2.5x change-in-control multiples, Roth at 1.0x and 2.0x
CEO Neil Brinker's offer letter amended October 22, 2026 to provide two times base salary plus target bonus on a qualifying termination outside a change in control
Performance stock awards now pay out at the greater of target or extrapolated performance upon a qualifying termination within 12 months after a change in control, without proration
Watsco entered an unsecured five-year, $750.0 million syndicated multicurrency credit agreement on October 21, 2026, replacing its $600.0 million revolving credit facility from March 2023. The company borrowed $69.7 million at closing to repay the prior facility, and the new facility matures on October 21, 2031. The filing describes the new terms, including pricing, sublimits and financial covenants, but does not state how the company plans to use the added capacity.
New $750.0 million unsecured credit facility dated October 21, 2026, replaces the $600.0 million facility entered into March 16, 2023
$69.7 million borrowed at closing; proceeds used to repay the prior facility, with $69.7 million outstanding as of the closing date
Interest at Term SOFR or Daily Simple SOFR plus 100.0 to 137.5 basis points (100.0 basis points at closing); unused commitment fee 10.0 to 17.5 basis points
Facility matures October 21, 2031; a $150,000 letter of credit from the prior facility remains outstanding and reduces availability
Baker Hughes Company announced its third-quarter 2026 financial results, reporting revenue of $8.0 billion and net income attributable to the company of $411 million, alongside the completion of the Chart Industries acquisition. Driven by strong commercial momentum, the company raised its full-year Industrial & Energy Technology order guidance and Horizon 2 order outlook to over $50 billion. Shareholders gain insight into segment performance across Oilfield Services & Equipment, IET, and Chart, with total remaining performance obligations ending at $46.4 billion.
Reported third-quarter 2026 revenue of $8.0 billion and GAAP diluted EPS of $0.41.
Generated $1,005 million in cash flows from operating activities and $769 million in free cash flow.
Raised full-year Industrial & Energy Technology order guidance and Horizon 2 order outlook to $50 billion plus.
Total remaining performance obligations reached $46.4 billion as of September 30, 2026.
EnerSys agreed to acquire Ultralife through a tender offer followed by a merger, at $16.00 per share in cash, with a total enterprise value of about $320 million. The deal will be funded from cash on hand and is expected to close in the first quarter of calendar 2027, subject to conditions including regulatory clearances.
Offer price is $16.00 per Ultralife share in cash, a 166% premium to the unaffected closing price on October 26, 2026
Enterprise value of approximately $320 million, funded through cash on hand
EnerSys expects $15 million to $20 million in annual run-rate cost synergies within the first 18 months
Ultralife would pay a $10,300,000 termination fee in specified circumstances; the outside date is April 27, 2027
Universal Health Services reported third-quarter 2026 net income attributable to UHS of $308.7 million, or $5.22 per diluted share, down from $373.0 million, or $5.86 per diluted share, a year earlier. Net revenues rose 5.3% to $4.733 billion, and the company said a tentative settlement of the Cumberland Litigation drove a $26 million reserve increase, which shareholders should weigh against the higher revenue.
Q3 2026 net income attributable to UHS was $308.7 million, or $5.22 per diluted share, versus $373.0 million, or $5.86, in Q3 2025
Net revenues rose 5.3% to $4.733 billion from $4.495 billion
A $26 million pre-tax reserve increase tied to the tentative Cumberland settlement was partly offset by $47 million in favorable Medicaid supplemental payments
Repurchased 1.35 million shares for about $242.1 million in Q3; about $735.4 million remained under the authorization as of September 30, 2026
OceanFirst Financial reported third-quarter 2026 net income available to common stockholders of $16.5 million, or $0.17 per diluted share, down from $17.3 million, or $0.30, a year earlier. Core earnings, which exclude non-core items such as $37.1 million of Flushing merger-related expenses, rose to $46.9 million, or $0.48 per diluted share, from $0.36 a year earlier. The Board also declared a $0.20 per share quarterly dividend payable November 20, 2026.
Q3 2026 net income available to common stockholders was $16.5 million, or $0.17 per diluted share, versus $17.3 million, or $0.30, in Q3 2025 and a net loss of $3.0 million, or $0.04, in the linked quarter.
Core diluted EPS was $0.48 for Q3 2026, up from $0.36 a year earlier and $0.43 in the linked quarter; nine-month GAAP EPS was $0.45 versus $0.94.
The quarter included $37.1 million of non-recurring merger-related expenses for the Flushing acquisition, completed June 1, 2026, equal to $0.30 per share after tax.
The quarterly dividend is $0.20 per share, payable November 20, 2026, to holders of record on November 9, 2026.
First Busey reported third-quarter 2026 net income of $55.8 million, or $0.61 per diluted share, down from $63.2 million, or $0.69, in the second quarter and $57.1 million, or $0.58, a year earlier. Adjusted diluted EPS was $0.63, compared with $0.69 in the prior quarter and $0.64 a year earlier, as a single commercial relationship in the Central region drove a higher provision for credit losses.
Provision for credit losses rose to $9.6 million from $2.2 million in the second quarter, mainly due to one commercial relationship totaling $37.6 million that moved to non-accrual status.
The company recorded a $10.0 million partial charge-off on that relationship, and non-performing assets rose $13.3 million from June 30, 2026, to $83.6 million.
Net interest income was $153.1 million, up $0.7 million from the second quarter, and noninterest income fell to $40.4 million from $44.3 million.
Year-to-date share repurchases totaled $188.4 million, including $59.6 million in the third quarter.
VolitionRx paid $500,000 in cash toward the principal of its $2.4 million senior secured convertible note held by Lind Global Asset Management XII LLC, leaving a balance of $706,667. Under an October 23, 2026 waiver, Lind agreed not to convert the note before January 1, 2027 unless the closing share price reaches $0.275, and the November and December 2026 repayments were deferred. The company says the moves reduce debt and pause conversion rights, which bear on potential share dilution, though the deferrals show the scheduled payments were pushed back.
$500,000 cash prepayment of principal on the note, with $706,667 remaining outstanding
Lind agreed not to exercise conversion rights on or before January 1, 2027, unless the closing price equals or exceeds $0.275 per share
November and December 2026 monthly repayments deferred and kept in outstanding principal
Waiver dated October 23, 2026; company press release issued October 27, 2026
Virtuix Holdings said it expects strong revenue growth for the fiscal second quarter ended September 30, 2026, driven partly by higher Omni One sales after the June launch of Omni One for Quest with Meta. The expectations are preliminary, the filing gives no revenue or profit figures, and final results remain subject to quarter-end closing procedures.
Company expects strong revenue growth for the quarter ended September 30, 2026, but the filing gives no specific figures.
Growth is attributed in part to Omni One sales following the June 2026 launch of Omni One for Quest with Meta.
Results conference call is set for Monday, November 16, 2026, at 8:30 a.m. Eastern Time, with CEO Jan Goetgeluk and CFO Thomas McGinnis presenting.
The call will also cover recent sales to the U.S. Army, U.S. Navy, and U.S. Department of Veterans Affairs.
Socket Mobile notified Nasdaq on October 27, 2026 that it intends to voluntarily withdraw its common stock from The Nasdaq Capital Market and move quotation to the OTCID Market under the same ticker, SCKT. The company said it was below Nasdaq's $2.5 million minimum stockholders' equity requirement and cited the costs of maintaining a Nasdaq listing; it also said operations and customer commitments will not be affected.
Written notice to Nasdaq delivered October 27, 2026 under Nasdaq Listing Rule 5840(j) and Rule 12d2-2(c)
Form 25 expected to be filed on or about November 9, 2026
Nasdaq trading expected to cease at market close on November 18, 2026; OTCID quotation expected to begin on or about November 19, 2026
Company cited Nasdaq's $2,500,000 minimum stockholders' equity requirement, which it no longer met as of an August 24, 2026 notification
First Carolina Financial Services reported net income of $7.9 million, or $0.26 per diluted share, for the quarter ended September 30, 2026, compared with a net loss of $2.0 million, or $0.08 per diluted share, a year earlier. Net interest income rose 10.0%, while noninterest income fell 48.0% on the planned discontinuation of a banking-as-a-service partnership and a prior-year securities gain. The filing furnishes the earnings release as Exhibit 99.1 and contains no guidance.
Net income of $7.9 million, or $0.26 per diluted share, versus a loss of $2.0 million, or $0.08 per diluted share, in Q3 2025.
Net interest income rose 10.0% to $28.1 million; net interest margin was 3.38%, up 32 basis points year over year.
Noninterest income fell 48.0% to $6.7 million, including $3.6 million from the discontinued partnership and $1.7 million in prior-year securities gains.
Noninterest expense fell 19.6% to $25.8 million; nonperforming assets were 0.60% of total assets at September 30, 2026, versus 0.63% a year earlier.
Cricut entered a new five-year, senior secured $300.0 million revolving credit facility led by BMO Bank N.A. as administrative agent, replacing its August 2022 credit agreement with JPMorgan Chase Bank, N.A. The company said no principal was outstanding under the prior facility when it was terminated, and no material early termination penalties were incurred. For shareholders, the filing is primarily a refinancing that adds committed borrowing capacity and permits dividends and share repurchases subject to a leverage test.
New $300.0 million revolving credit facility matures October 22, 2031
Pricing ranges from 1.125% to 2.00% above Adjusted Term SOFR, based on Net Leverage Ratio
Covenants require maximum Net Leverage Ratio of 3.00 to 1.00 and minimum Interest Coverage Ratio of 3.00 to 1.00
Prior credit agreement with JPMorgan Chase Bank, N.A. terminated October 22, 2026 with no principal outstanding
Fortune Brands Innovations, Inc. announced several leadership changes, including Executive Vice President and Chief Operating Officer Dave Barry's move to lead the Moen business and the hiring of Peter DuBois as Chief Information Officer. The company said the changes are meant to give its businesses more focus and speed up execution, and the filing gives no financial figures for the changes.
Dave Barry moves from Executive Vice President and Chief Operating Officer to Executive Vice President and President, Moen; the company determined this on October 22, 2026
Peter DuBois joins as Executive Vice President and Chief Information Officer effective November 2, 2026, reporting to CEO Jesse Singh; he previously was Chief Digital and Technology Officer of Serta Simmons Bedding
John D. Lee moves to Executive Vice President and Chief Innovation Officer effective November 2, 2026, and will focus on R&D and Consumer Services
Rachel Roberts becomes Chief Commercial Officer for Moen; Matt Zimmer, General Manager of House of Rohl since June 2026, will report directly to Singh
RenaissanceRe reported a third-quarter 2026 net loss attributable to common shareholders of $161.4 million, or $(4.02) per diluted share, compared with net income of $907.7 million, or $19.40 per diluted share, a year earlier. Operating income available to common shareholders fell to $512.6 million, or $12.71 per diluted share, from $733.7 million, or $15.62, and the combined ratio rose to 79.7% from 68.4%, reflecting 2026 large loss events, mainly the Middle East War, the Ras Laffan Explosion and the Colombian Earthquake, and mark-to-market investment losses.
Net loss attributable to common shareholders of $161.4 million, or $(4.02) per diluted share, versus net income of $907.7 million, or $19.40, in Q3 2025.
Operating income available to common shareholders of $512.6 million, or $12.71 per diluted share, versus $733.7 million, or $15.62, in Q3 2025.
Combined ratio of 79.7% versus 68.4%; 2026 Large Loss Events reduced the underwriting result by $191.4 million.
Repurchased $310.1 million of common shares in Q3 2026 and a further $143.8 million from October 1 to October 23, 2026.
Bowman Consulting Group Ltd. filed a supplement to its proxy statement for its pending merger with Prive Parent, Inc., an affiliate of Bernhard Capital Partners, after receiving stockholder demand letters and two New York lawsuits. The lawsuits seek to block the merger until more disclosures are made, or alternatively rescission or damages. The company says the claims are without merit, but it added the disclosures to avoid delays to the merger and to limit defense costs.
Merger agreement dated August 10, 2026; special meeting of stockholders set for November 4, 2026
Two lawsuits filed in New York Supreme Court: Smith on October 14, 2026 and Scott on October 15, 2026, naming the company and each board member
Supplemental disclosures include a BofA Securities analysis applying 10.5x to 13.5x to adjusted EBITDA of $79 million for the 12 months ended June 30, 2026
O-I Glass reported third-quarter 2026 net sales of $1.6 billion, down 2 percent, and a net loss of $13 million, or $0.08 per share, compared with net earnings of $30 million, or $0.19 per share, a year earlier. The company lowered its 2026 adjusted EBITDA outlook to $925 million to $950 million from $1.0 billion to $1.1 billion, citing energy and freight inflation, soft demand and a slower European recovery, and said it is starting a process on the proposed permanent closure of a European plant.
Q3 2026 net sales were $1.623 billion versus $1.653 billion; net loss attributable to the company was $13 million versus net income of $30 million in Q3 2025.
Adjusted EBITDA was $234 million versus $329 million; Europe segment operating profit fell to $2 million from $95 million.
2026 adjusted EBITDA guidance is $925 million to $950 million, down from $1.0 billion to $1.1 billion; free cash flow use is expected to be about $300 million.
The company expects $100 million to $120 million in charges in Q4 2026 related to the proposed closure of a European production facility.
Cardiff Oncology said its Chief Medical Officer, Roger Sidhu, separated from the company on October 22, 2026, in a mutually agreed transition. The company appointed Dr. Leila Alland as interim Chief Medical Officer under a consulting agreement, and it also increased its authorized common stock to 300,000,000 shares. The filing does not include financial results or guidance.
Roger Sidhu separated from the company as Chief Medical Officer on October 22, 2026, in a mutually agreed transition.
Dr. Leila Alland's consulting agreement began October 23, 2026, and runs until April 22, 2027, or earlier if all services are completed.
Dr. Alland will be paid a monthly fee of $35,000 and will devote up to 50% of her professional time to the role.
Authorized common stock was increased to 300,000,000 shares, effective October 22, 2026.
First Guaranty Bancshares reported third-quarter 2026 net income of $12.0 million, compared with a $45.0 million loss in the same period of 2025. Results were shaped by the July 31, 2026 sale of its Texas operations and by strategic changes made in response to a Consent Order from the FDIC and OFI, effective August 7, 2026. Net interest income fell to $17.7 million from $22.2 million, and total assets declined $925.8 million since December 31, 2025.
Q3 2026 net income was $12.0 million, or $0.69 per share, versus a loss of $(45.0) million, or $(3.01) per share, in Q3 2025.
Net interest income was $17.7 million versus $22.2 million a year earlier, and net interest margin was 2.08% versus 2.34%.
Net gains on sale of branches were $16.1 million in Q3 2026, tied to the sale of the Texas operations to Armstrong Bank.
Total assets were $3.2 billion at September 30, 2026, down from $4.1 billion at December 31, 2025; total deposits fell 21.4% over the same period.
Home Federal Bancorp, Inc. of Louisiana reported net income of $1.911 million, or $0.62 per diluted share, for the three months ended September 30, 2026, up from $1.599 million, or $0.52 per diluted share, a year earlier. Higher net interest income and non-interest income drove the increase, while non-performing assets fell sharply from June 30, 2026.
Net income of $1.911 million vs. $1.599 million a year earlier; diluted EPS of $0.62 vs. $0.52
Net interest income rose $643,000, or 12.2%; net interest margin was 3.83% vs. 3.63%
Non-interest income rose $203,000, or 31.2%, including a $204,000 gain on the bulk sale of 44 rental properties
Non-performing assets were $1.556 million at September 30, 2026, down from $3.649 million at June 30, 2026
Trustmark reported third quarter 2026 net income of $58.1 million, or $1.00 per diluted share, down from $63.5 million and $1.08 per diluted share in the prior quarter, and up from $56.8 million and $0.94 a year earlier. Revenue was $207.1 million, down 0.5% from the prior quarter and up 2.4% year over year. The company also declared a $0.25 quarterly dividend.
Net income $58.1 million and diluted EPS $1.00, versus $1.08 in the second quarter of 2026 and $0.94 in the third quarter of 2025
Revenue $207.1 million, down 0.5% linked-quarter and up 2.4% year over year; net interest income (FTE) $170.6 million, up 1.2% linked-quarter
A $61.5 million pre-tax gain from a branch sale-leaseback was offset by a $61.5 million securities loss from a portfolio restructuring
Quarterly dividend of $0.25 per share payable December 15, 2026, to holders of record on December 1, 2026
Georgia Banking Company, Inc. said its common stock has been approved for direct listing on the Nasdaq Capital Market and is expected to begin trading under the ticker GBC on Thursday, October 29, 2026. The company said no new shares will be issued or sold in connection with the listing, which covers the potential resale of up to 7,074,016 shares by selling shareholders, so the listing itself does not raise new capital for the company but may add liquidity and a public trading price for existing shareholders.
Trading expected to begin Thursday, October 29, 2026, under the ticker GBC on the Nasdaq Capital Market
No new shares will be issued or sold by the company in connection with the listing
Registration Statement on Form S-1 covers potential resale of up to 7,074,016 shares by selling shareholders
As of September 30, 2026, the bank had approximately $3.1 billion in total assets
Peapack-Gladstone reported third-quarter 2026 net income available to common shareholders of $18.5 million, or $0.99 per diluted share, up from $9.6 million, or $0.54, a year earlier. Total revenue rose 24% year over year to $87.5 million, and operating expenses rose 5% year over year. The company also issued the remaining $20 million of its 6% convertible preferred stock and reinstated a 3% discount feature in its Dividend Reinvestment Plan.
Net income available to common shareholders of $18.5 million, or $0.99 diluted EPS, versus $9.6 million, or $0.54, in Q3 2025
Total revenue of $87.5 million, up 24% year over year; net interest income of $67.5 million, up 33%
Remaining $20 million of 6% non-cumulative perpetual convertible preferred stock issued on July 24, 2026
Dividend Reinvestment Plan share purchases at a 3% discount to market price take effect with the November 2026 dividend
Waste Management reported its third quarter 2026 financial results, posting revenue of $6.85 billion and net income of $820 million, or $2.05 per diluted share. The company returned $957 million to shareholders during the quarter through share repurchases and cash dividends, and affirmed its full-year 2026 financial guidance.
Total company revenue grew 6.3% to $6.85 billion for the third quarter of 2026.
Net cash provided by operating activities reached $4.87 billion for the first nine months of the year.
The company returned $957 million to shareholders during the third quarter, consisting of $580 million in share repurchases and $377 million in cash dividends.
WM expects full-year 2026 revenue to be at the high end of its guidance range of $26.275 to $26.475 billion.
CooperCompanies said Albert G. White III stepped down as President, Chief Executive Officer and director on October 27, 2026, and independent director Walter M. Rosebrough, Jr. was named interim Executive Chair. The press release said the company's recent performance has not met expectations, and the company reaffirmed its fiscal 2026 guidance. Shareholders face a leadership change while a permanent CEO is sought, and the board is changing composition with Shlomo Nachman joining in December 2026 and three directors not seeking reelection.
Albert G. White III resigned as President, CEO and director effective October 27, 2026, and will remain a strategic advisor through April 1, 2027.
Walter M. Rosebrough, Jr. was appointed interim Executive Chair effective immediately; a CEO Search Committee of Lawrence E. Kurzius, Cynthia L. Lucchese and Teresa S. Madden will oversee the CEO search.
Shlomo Nachman will join the board effective December 8, 2026; Barbara Carbone, Colleen E. Jay and Robert S. Weiss will not stand for reelection at the 2027 Annual Meeting.
The company reaffirmed its fiscal 2026 guidance provided on September 9, 2026.
Essex Property Trust reported third quarter 2026 Core FFO of $4.00 per diluted share, up 0.8% from $3.97 a year earlier, and raised its full-year 2026 Core FFO guidance midpoint by $0.02 to $16.16. Net income per diluted share fell 40.6% to $1.52, mainly because of gains on real estate sales recognized in the third quarter of 2025.
Q3 2026 Core FFO per diluted share was $4.00 versus $3.97 in Q3 2025; it exceeded the guidance midpoint by $0.01, driven by same-property revenue growth.
Q3 2026 net income per diluted share was $1.52 versus $2.56 in Q3 2025, a 40.6% decrease.
Full-year 2026 guidance: Core FFO range revised to $16.10 to $16.22 (midpoint $16.16); net income range revised to $5.62 to $5.74 (midpoint $5.68, up $0.10).
Same-property revenue grew 3.0% year over year in Q3 2026; same-property NOI grew 3.1%.
Renasant reported third-quarter 2026 net income of $78.9 million, or $0.86 per diluted share, down from $87.1 million and $0.94 in the second quarter but up from $59.8 million and $0.63 a year earlier, when merger and conversion expenses weighed on results. Loans rose $555.9 million linked quarter, and the board approved a $175.0 million stock repurchase program effective October 27, 2026.
Net income $78.9 million vs. $87.1 million in Q2 2026 and $59.8 million in Q3 2025
Net interest margin 3.77%, down 6 basis points linked quarter
Provision for credit losses $13.3 million vs. $3.8 million in Q2 2026
Board approved a $175.0 million repurchase program; $42.6 million of stock was bought back in Q3 2026
NextNRG received a Nasdaq notice that its market value of listed securities stayed below the $35,000,000 minimum for 30 consecutive business days, and it does not meet the alternative equity or net income standards. The notice has no immediate effect on trading, and the company has until April 19, 2027 to regain compliance, but a separate delisting determination is under appeal before a Nasdaq Hearings Panel with no decision yet issued.
Nasdaq notice dated October 21, 2026 cites MVLS below $35,000,000 from September 9, 2026 through October 20, 2026.
Compliance deadline is April 19, 2027, under a 180-day period.
Company is appealing a September 15, 2026 delisting determination; hearing held October 22, 2026, and the Panel's written decision is pending.
Company effected a one-for-ten reverse split effective September 14, 2026.
Goodyear said Jerome J. Rouquet, currently CFO of Visteon Corporation, will become Executive Vice President and Chief Financial Officer effective December 1, 2026. Scott M. Deakin continues as Interim CFO through November 30, 2026. The filing also details a compensation package for Rouquet, which includes a base salary of $900,000 and a long-term incentive award valued at $3,200,000.
Jerome J. Rouquet becomes EVP and CFO effective December 1, 2026; Scott M. Deakin serves as interim CFO through November 30, 2026
Rouquet has been SVP and CFO of Visteon Corporation since February 2020; he is 59 years old
Base salary of $900,000 and target annual incentive of $900,000
Make-whole and inducement awards include a $2,500,000 cash payment on March 15, 2027 and Restricted Stock Unit awards of $2,600,000 and $700,000
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.